BWX Technologies (NYSE:BWXT) Shares Acquired Rep. April McClain Delaney

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on June 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in BWX Technologies stock on May 7th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Hubbell (NYSE:HUBB) on 5/29/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of Martin Marietta Materials (NYSE:MLM) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of Hubbell (NYSE:HUBB) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of EMCOR Group (NYSE:EME) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of Viking (NYSE:VIK) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of Viking (NYSE:VIK) on 5/27/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/27/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/26/2026.

BWX Technologies Stock Down 1.0%

Shares of NYSE BWXT traded down $1.87 during mid-day trading on Tuesday, reaching $185.59. The company had a trading volume of 529,997 shares, compared to its average volume of 1,025,226. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.33 and a current ratio of 2.40. The company has a market capitalization of $17.00 billion, a price-to-earnings ratio of 49.70, a PEG ratio of 3.06 and a beta of 0.73. The stock has a fifty day moving average of $210.54 and a two-hundred day moving average of $199.78. BWX Technologies, Inc. has a 12-month low of $128.96 and a 12-month high of $241.82.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings data on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.20. The firm had revenue of $860.22 million for the quarter, compared to the consensus estimate of $837.47 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The firm’s revenue was up 26.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 earnings per share. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. As a group, equities research analysts expect that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were issued a $0.27 dividend. The ex-dividend date was Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio is currently 28.88%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in BWXT. Aventura Private Wealth LLC acquired a new stake in BWX Technologies in the 4th quarter worth approximately $29,000. Strategic Advocates LLC acquired a new position in BWX Technologies during the third quarter valued at approximately $32,000. MV Capital Management Inc. acquired a new position in BWX Technologies during the fourth quarter valued at approximately $32,000. Strategic Investment Solutions Inc. IL raised its position in shares of BWX Technologies by 300.0% in the third quarter. Strategic Investment Solutions Inc. IL now owns 200 shares of the technology company’s stock valued at $37,000 after purchasing an additional 150 shares during the period. Finally, WFA of San Diego LLC acquired a new stake in shares of BWX Technologies in the second quarter worth $29,000. Institutional investors and hedge funds own 94.39% of the company’s stock.

Insider Buying and Selling at BWX Technologies

In related news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the sale, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. This represents a 25.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Rex D. Geveden sold 10,000 shares of BWX Technologies stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares in the company, valued at $41,472,181.71. This trade represents a 4.71% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

BWXT has been the topic of several research analyst reports. Weiss Ratings restated a “buy (b-)” rating on shares of BWX Technologies in a report on Friday, May 22nd. Truist Financial increased their price objective on BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a report on Monday, May 11th. Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. TD Securities initiated coverage on BWX Technologies in a research note on Thursday, March 12th. They issued a “buy” rating and a $230.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft raised BWX Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $205.00 to $255.00 in a research report on Friday, May 15th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $228.00.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.